CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $25,980
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-12-26 | EPIC INVESTMENTS, LLC 10% owner | Sale | −561,000 | $0.09 | $51K | 9,328,002 |
| 2012-12-21 | POTTI RAM Director | Other disposition | −17,005,400 | $0.04 | $627K | 10,120,655 |
| 2012-12-21 | POTTI RAM Director | Other disposition · Warrants | −8,366,667 | 15,135,332 | ||
| 2012-12-21 | NIGALAYE ASHOK G Chief Scientific Officer | Other disposition | −17,005,420 | $0.04 | $627K | 10,528,604 |
| 2012-12-21 | NIGALAYE ASHOK G Chief Scientific Officer | Other disposition · Warrants | −8,366,667 | 15,135,332 | ||
| 2012-12-21 | NARINE JEENARINE Director | Other disposition | −17,005,400 | $0.04 | $627K | 10,528,584 |
| 2012-12-21 | NARINE JEENARINE Director | Other acquisition · Warrants | +8,366,667 | 15,135,332 | ||
| 2012-12-21 | EPIC PHARMA LLC 10% owner | Other acquisition | +17,005,400 | $0.04 | $627K | 9,889,002 |
| 2012-12-21 | EPIC PHARMA LLC 10% owner | Other acquisition · Warrants | +8,366,667 | 15,135,332 | ||
| 2012-12-21 | EPIC INVESTMENTS, LLC 10% owner | Other disposition | −17,005,420 | $0.04 | $627K | 9,889,002 |
| 2012-12-21 | EPIC INVESTMENTS, LLC 10% owner | Other disposition · Warrants | −8,366,667 | 15,135,332 | ||
| 2012-12-19 | POTTI RAM Director | Sale | −243,300 | $0.09 | $22K | 27,126,055 |
| 2012-12-19 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −243,300 | $0.09 | $22K | 27,534,004 |
| 2012-12-19 | NARINE JEENARINE Director | Sale | −243,300 | $0.09 | $22K | 27,534,004 |
| 2012-12-19 | EPIC PHARMA LLC 10% owner | Sale | +243,300 | $0.09 | $22K | 26,894,422 |
| 2012-12-19 | EPIC INVESTMENTS, LLC 10% owner | Sale | −243,300 | $0.09 | $22K | 26,894,442 |
| 2012-12-10 | Ward Carter Julian Chief Financial Officer, Sec. | Sale | −201,192 | $0.08 | $16K | 1,669,555 |
| 2012-09-10 | NARINE JEENARINE Director | Grant or award · Series E Convertible Preferred Stock | +250 | $1,000.00 | $250K | 2,187.5 |
| 2012-09-10 | NIGALAYE ASHOK G Chief Scientific Officer | Grant or award · Series E Convertible Preferred Stock | +250 | $1,000.00 | $250K | 2,187.5 |
| 2012-09-10 | POTTI RAM Director | Grant or award · Series E Convertible Preferred Stock | +250 | $1,000.00 | $250K | 2,187.5 |
Page 20 of 28 · 542 trades